Fletcher Building Limited (ASX:FBU)
Australia · Delayed Price · Currency is AUD 2.790
-0.010 (-0.36%)
Jul 31, 2025, 4:10 PM AEST
SpringWorks Therapeutics Income Statement
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
| 7,406 | 7,683 | 7,679 | 8,498 | 8,120 | 7,309 | Upgrade | |
Revenue Growth (YoY) | -0.82% | 0.05% | -9.64% | 4.66% | 11.10% | -12.03% | Upgrade |
Cost of Revenue | 5,355 | 5,521 | 5,282 | 5,989 | 5,778 | 5,496 | Upgrade |
Gross Profit | 2,051 | 2,162 | 2,397 | 2,509 | 2,342 | 1,813 | Upgrade |
Selling, General & Admin | 1,648 | 1,665 | 1,662 | 1,786 | 1,693 | 1,660 | Upgrade |
Operating Expenses | 1,648 | 1,665 | 1,662 | 1,786 | 1,693 | 1,660 | Upgrade |
Operating Income | 403 | 497 | 735 | 723 | 649 | 153 | Upgrade |
Interest Expense | -239 | -232 | -174 | -117 | -124 | -178 | Upgrade |
Interest & Investment Income | 54 | 54 | 39 | 23 | 22 | 48 | Upgrade |
Earnings From Equity Investments | 7 | 10 | 34 | 24 | 19 | 7 | Upgrade |
Other Non Operating Income (Expenses) | -22 | -22 | -12 | -10 | -6 | -19 | Upgrade |
EBT Excluding Unusual Items | 203 | 307 | 622 | 643 | 560 | 11 | Upgrade |
Merger & Restructuring Charges | - | - | - | -1 | - | -276 | Upgrade |
Impairment of Goodwill | -90 | -90 | - | - | - | - | Upgrade |
Asset Writedown | -37 | -38 | 16 | 9 | - | - | Upgrade |
Other Unusual Items | -220 | -213 | -301 | -53 | -128 | - | Upgrade |
Pretax Income | -134 | -24 | 337 | 598 | 432 | -265 | Upgrade |
Income Tax Expense | 16 | 55 | 88 | 159 | 115 | -81 | Upgrade |
Earnings From Continuing Operations | -150 | -79 | 249 | 439 | 317 | -184 | Upgrade |
Earnings From Discontinued Operations | -87 | -141 | 5 | - | - | - | Upgrade |
Net Income to Company | -237 | -220 | 254 | 439 | 317 | -184 | Upgrade |
Minority Interest in Earnings | -4 | -7 | -19 | -7 | -12 | -12 | Upgrade |
Net Income | -241 | -227 | 235 | 432 | 305 | -196 | Upgrade |
Net Income to Common | -241 | -227 | 235 | 432 | 305 | -196 | Upgrade |
Net Income Growth | - | - | -45.60% | 41.64% | - | - | Upgrade |
Shares Outstanding (Basic) | 862 | 783 | 783 | 807 | 824 | 835 | Upgrade |
Shares Outstanding (Diluted) | 862 | 783 | 848 | 880 | 867 | 835 | Upgrade |
Shares Change (YoY) | 3.98% | -7.66% | -3.64% | 1.50% | 3.83% | -12.20% | Upgrade |
EPS (Basic) | -0.28 | -0.29 | 0.30 | 0.54 | 0.37 | -0.23 | Upgrade |
EPS (Diluted) | -0.28 | -0.29 | 0.28 | 0.50 | 0.36 | -0.23 | Upgrade |
EPS Growth | - | - | -43.55% | 38.12% | - | - | Upgrade |
Free Cash Flow | 139 | -4 | -57 | 193 | 658 | 170 | Upgrade |
Free Cash Flow Per Share | 0.16 | -0.01 | -0.07 | 0.22 | 0.76 | 0.20 | Upgrade |
Dividend Per Share | - | - | 0.340 | 0.400 | 0.300 | - | Upgrade |
Dividend Growth | - | - | -15.00% | 33.33% | - | - | Upgrade |
Gross Margin | 27.69% | 28.14% | 31.21% | 29.52% | 28.84% | 24.80% | Upgrade |
Operating Margin | 5.44% | 6.47% | 9.57% | 8.51% | 7.99% | 2.09% | Upgrade |
Profit Margin | -3.25% | -2.96% | 3.06% | 5.08% | 3.76% | -2.68% | Upgrade |
Free Cash Flow Margin | 1.88% | -0.05% | -0.74% | 2.27% | 8.10% | 2.33% | Upgrade |
EBITDA | 564 | 670 | 899 | 888 | 821 | 338 | Upgrade |
EBITDA Margin | 7.61% | 8.72% | 11.71% | 10.45% | 10.11% | 4.62% | Upgrade |
D&A For EBITDA | 161 | 173 | 164 | 165 | 172 | 185 | Upgrade |
EBIT | 403 | 497 | 735 | 723 | 649 | 153 | Upgrade |
EBIT Margin | 5.44% | 6.47% | 9.57% | 8.51% | 7.99% | 2.09% | Upgrade |
Effective Tax Rate | - | - | 26.11% | 26.59% | 26.62% | - | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.